⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

December 30, 2019Annals of Internal Medicine

Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis

Philip G. Conaghan M.A. Bowes Sarah R. Kingsbury Alan Brett Gwenael Guillard Biljana Rizoska Niclas Sjögren Philippa Graham Åsa Jansson Cecilia Wadell Richard C. Bethell John Öhd

View at Publisher

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Medivir.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Conaghan et al. (2019) studied this question.

synapsesocial.com/papers/69df3d6635659245ec614273 https://doi.org/10.7326/m19-0675

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Femorotibial subchondral bone area and regional cartilage thickness: A cross‐sectional description in healthy reference cases and various radiographic stages of osteoarthritis in 1,003 knees from the Osteoarthritis InitiativeCross-Sectional Study · 2010 · 74 citations
2The relationship between clinical characteristics, radiographic osteoarthritis and 3D bone area: data from the Osteoarthritis InitiativeCross-Sectional Study · 2014 · 21 citations
3Brief Report: Cartilage Thickness Change as an Imaging Biomarker of Knee Osteoarthritis Progression: Data From the Foundation for the National Institutes of Health Osteoarthritis Biomarkers ConsortiumCohort Study · 2015 · 173 citations
4Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly Expressed in Human OsteoclastsOriginal Research · 1996 · 721 citations
5Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711In Vitro Study · 2018 · 45 citations

Effect of ONO-5334 on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Osteoporosis: 2-Year Results From the OCEAN Study2013
Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect2010
The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis2018
Impact of Unrestricted Artificial Intelligence Scribe Deployment in a Single Health System on Clinician Workload and ProductivityAnnals of Internal Medicine · 2026
The Hidden Human Costs of Ambient ScribesAnnals of Internal Medicine · 2026

More from Annals of Internal Medicine

More from University of Leeds

More from NIHR Leeds Musculoskeletal Biomedical Research Unit

More from Medivir (Sweden)